SCM
PFE icon

Stellar Capital Management’s Pfizer PFE Stock Holding History

Stellar Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$390K Sell
12,586
-60
-0.5% -$2.04K 0.27% 58
2020
Q1 		$392K Sell
12,646
-186
-1% -$6.34K 0.32% 53
2019
Q4 		$477K Buy
12,832
+232
+2% +$8.26K 0.28% 58
2019
Q3 		$430K Buy
12,600
+14
+0.1% +$509 0.28% 62
2019
Q2 		$507K Hold
12,586
– – 0.33% 59
2019
Q1 		$507K Buy
12,586
+77
+0.6% +$3.08K 0.33% 59
2018
Q4 		$519K Buy
12,509
+5
+0% +$208 0.41% 54
2018
Q3 		$523K Sell
12,504
-2,169
-15% -$83.5K 0.34% 59
2018
Q2 		$505K Sell
14,673
-794
-5% -$27.1K 0.33% 59
2018
Q1 		$521K Buy
15,467
+2,114
+16% +$72.7K 0.34% 57
2017
Q4 		$459K Buy
13,353
+6
+0% +$205 0.3% 59
2017
Q3 		$452K Buy
13,347
+7
+0.1% +$225 0.32% 59
2017
Q2 		$425K Sell
13,340
-405
-3% -$12.8K 0.31% 61
2017
Q1 		$446K Sell
13,745
-298
-2% -$9.4K 0.34% 58
2016
Q4 		$433K Buy
+14,043
New +$429K 0.36% 58
2016
Q2 		$460K Buy
13,783
+610
+5% +$19.5K 0.5% 47
2016
Q1 		$370K Sell
13,173
-102
-0.8% -$2.91K 0.41% 54
2015
Q4 		$407K Hold
13,275
– – 0.49% 48
2015
Q3 		$396K Buy
13,275
+606
+5% +$19.4K 0.51% 46
2015
Q2 		$403K Sell
12,669
-198
-2% -$6.45K 0.44% 50
2015
Q1 		$425K Hold
12,867
– – 0.41% 54
2014
Q4 		$380K Hold
12,867
– – 0.41% 52
2014
Q3 		$361K Hold
12,867
– – 0.4% 54
2014
Q2 		$362K Sell
12,867
-394
-3% -$11.2K 0.4% 54
2014
Q1 		$404K Hold
13,261
– – 0.45% 53
2013
Q4 		$385K Buy
+13,261
New +$386K 0.41% 56

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Stellar Capital Management's PFE Position: Q2 2020 in Review

Stellar Capital Management reduced its Pfizer (PFE) stake by 0.47% in Q2 2020, selling an estimated $2.04K and leaving 12,586 shares worth $390K. The position accounts for 0.27% of the portfolio, ranked #58.

Stellar Capital Management first reported a position in PFE in Q4 2013 and has held it in 26 quarters since. The position peaked at $523K in Q3 2018. 2,441 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

  • Stellar Capital Management held 12,586 shares of Pfizer worth $390K as of Q2 2020.
  • Stellar Capital Management sold 60 Pfizer shares in Q2 2020, an estimated $2.04K.
  • Pfizer made up 0.27% of Stellar Capital Management's portfolio in Q2 2020, its #58 holding.
  • Stellar Capital Management first reported a position in Pfizer in Q4 2013 and has held it in 26 quarters since.
  • Stellar Capital Management's Pfizer position peaked at $523K in Q3 2018.
  • 2,441 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Stellar Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.